Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaPrakash Satwani, Mitchell S. Cairo, Paul L. Martin et al.|Leukemia|2014Cited by 53